‘CBD supports the immune system’: Austrian clinic reports promising results from cannabis trial on Covid-19 ICU patients

Researchers in Austria’s Klagenfurt Clinic are reporting promising results from CBD trials on Covid-19 ICU patients that show reduced inflammation and quicker recovery times.

Cannabidiol or CBD oil was used as part of the overall course of treatment for Covid-19 patients in the hospital’s ICU over the course of three weeks. 

Rudolf Likar, head of intensive care medicine at the clinic, started by administering a dose of 200 milligrams of CBD per day which later increased to 300 milligrams. 

“We have seen that the inflammation parameters in the blood go down and people leave the hospital faster than the comparison group,” Likar said. “CBD supports the immune system.”

Keep reading

Constitutional ban on legal cannabis advances in Idaho

As legal marijuana becomes a reality in every corner of the U.S., Idaho is putting up a fight.

State lawmakers on Friday moved forward with a proposed constitutional amendment that would bar the legalization of marijuana in Idaho in an attempt to keep the growing nationwide acceptance of the drug from seeping across its borders.

Idaho is one of only three states without some sort of policy allowing residents to possess products with even low amounts of THC, the psychoactive chemical in marijuana. Residents can cross the state border in nearly every direction and find themselves in a place where marijuana can be bought for recreational or medicinal purposes. Support for medicinal marijuana use is growing among some residents — with legalization activists trying to get an initiative on the state ballot in 2022.

It’s made some lawmakers in the deep-red state nervous, particularly after voters in the neighboring state of Oregon decriminalized the personal possession of drugs like heroin, cocaine and methamphetamine last November.

The joint resolution to ban all psychoactive drugs not already legal in Idaho won approval along a 6-2 party-line vote in the Senate State Affairs Committee. The list of substances would change for drugs approved by the Food and Drug Administration.

But the primary target over the two days of testimony on Monday and Friday was marijuana as Idaho finds itself surrounded by states that have legalized cannabis.

Keep reading

Governor Noem issues executive order against legalizing marijuana

Governor Kristi Noem issued an executive order Friday, January 8, against Amendment A, which would legalize recreational marijuana in the state of South Dakota. This move officially backs South Dakota Highway Patrol Superintendent Col. Rick Miller and Pennington County Sheriff Kevin Thom, who originally filed the lawsuit.

Noem says she will be directing the suit challenging the amendment and has the authority to do so. She claims the process used to put it on the ballot violates the state constitution. A motions hearing is scheduled for January 27th.

Keep reading

Novel cannabis plant extracts could protect against COVID-19

Researchers in Canada have conducted a study suggesting that novel Cannabis sativa extracts may decrease levels of the host cell receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain viral entry to target tissues.

SARS-CoV-2 is the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic that continues to sweep the globe threatening public health and the worldwide economy.

The team – from the University of Lethbridge and Pathway Rx Inc., Lethbridge – developed hundreds of new C. sativa cultivars and tested 23 extracts in artificial 3D human models of the oral, airway and intestinal tissues.

As recently reported in the journal Aging, 13 of the extracts downregulated expression of the SARS-CoV-2 host cell receptor angiotensin-converting enzyme 2 (ACE2).

“The observed down-regulation of ACE2 gene expression by several tested extracts of new C. sativa cultivars is a novel and crucial finding,” say the researchers.

“While our most effective extracts require further large-scale validation, our study is important for future analyses of the effects of medical cannabis on COVID-19,” write Olga Kovalchuk and colleagues.

Keep reading